| Biotechnology Industry | Healthcare Sector | Mr. William P. Hales CEO | OTC PINK Exchange | 423501105 CUSIP |
| US Country | 15 Employees | - Last Dividend | - Last Split | 4 Feb 1993 IPO Date |
Hemagen Diagnostics, Inc. is a biotechnology firm that has been playing a pivotal role in the healthcare sector since its inception in 1985. Based in Columbia, Maryland, Hemagen has made significant strides in providing comprehensive clinical diagnostic solutions not only for humans but also for veterinary applications across the globe. The company’s dedication to innovation and quality has established it as a reputable supplier in the diagnostics field, catering to the needs of laboratories, hospitals, and blood banks through both direct sales and a network of distributors.
Hemagen Diagnostics, Inc. offers a broad array of products and services tailored to meet the diagnostic needs of both human and veterinary health sectors. Their product line includes: